Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.4B | 3.7B | 4.0B | 4.6B |
Cost of revenue | 16.8M | 17.8M | 21.4M | 47M |
Gross profit | 3.4B | 3.7B | 3.9B | 4.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.1B | 2.1B | 2.1B | 2.5B |
Operating income | -90.4M | 155.3M | 240.6M | 594.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 644.5M | 710.5M | 664.1M | 667.4M |
Other income expense | — | — | — | — |
Pretax income | -4.0B | -465.4M | -373.8M | -15.6M |
Tax provision | 0 | 0 | 0 | 0 |
Net income | -4.0B | -465.4M | -373.8M | -15.6M |
Basic EPS | — | -0.2 | 0.0 | 0.0 |
Diluted EPS | — | -0.2 | 0.0 | 0.0 |
Basic average shares | — | 1.9B | 1.8B | 1.6B |
Diluted average shares | — | 1.9B | 1.8B | 1.6B |
EBITDA | 1.0B | 1.3B | 1.5B | 1.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |